SYNTHEGO
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic... development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology. The company was founded in 2012 and is based in Redwood City, California.
SYNTHEGO
Industry:
Artificial Intelligence (AI) Biotechnology Genetics Industrial Automation Innovation Management Life Science Machine Learning Software
Founded:
2012-07-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.synthego.com
Total Employee:
251+
Status:
Active
Contact:
(888)611-6883
Email Addresses:
[email protected]
Total Funding:
459.69 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Mobile Non Scaleable Content Cloudflare Hosting Apache Contact Form 7 CrUX Top 50m Amazon Virginia Region Apache 2.4 Amazon S3
Similar Organizations
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Verne Bioanalytics
We combine novel scalable testing protocols with Data Analytics to Improve our Client's Bottom Line Through Repeatable Plant Health Outcomes
Current Advisors List
Current Employees Featured
Founder
Investors List
AAF Management Ltd.
AAF Management Ltd. investment in Series E - Synthego
RA Capital Management
RA Capital Management investment in Series E - Synthego
Laurion Capital Management
Laurion Capital Management investment in Series E - Synthego
Moore Strategic Ventures
Moore Strategic Ventures investment in Series E - Synthego
Wellington Management
Wellington Management investment in Series E - Synthego
Logos Capital
Logos Capital investment in Series E - Synthego
Chimera Investment
Chimera Investment investment in Series E - Synthego
Gigafund
Gigafund investment in Series E - Synthego
Perceptive Advisors
Perceptive Advisors investment in Series E - Synthego
Declaration Partners
Declaration Partners investment in Series E - Synthego
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2024-03-27 | Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics |
Official Site Inspections
http://www.synthego.com Semrush global rank: 439.08 K Semrush visits lastest month: 80.09 K
- Host name: 172.67.138.95
- IP address: 172.67.138.95
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Synthego"
About Us - Synthego
Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise. Our mission is to provide unparalleled …See details»
Synthego - Crunchbase Company Profile & Funding
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build …See details»
Synthego Company Profile 2025: Valuation, Funding
When was Synthego founded? Synthego was founded in 2012. Where is Synthego headquartered? Synthego is headquartered in Redwood City, CA. What is the size of Synthego? Synthego has 266 total employees. What industry is …See details»
Synthego Corporation - LinkedIn
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health.See details»
Synthego - Company Profile - Tracxn
3 days ago Synthego - Developer of CRISPR-engineered cell and gene therapies. Raised a total funding of $460M over 8 rounds from 32 investors. Founded by Paul Dabrowski, Alex Pesch …See details»
Synthego - Scientist.com
Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise. …See details»
Synthego - VentureRadar
"Synthego is the genome engineering innovation company. The company's automated, full-stack genome engineering platform enables broader access to CRISPR to accelerate basic scientific …See details»
Synthego - Golden
Synthego is a privately held, genome engineering innovation company headquartered in Redwood, California and was founded in 2012 by Alex Pesch, Michael Dabrowski, Paul …See details»
Synthego is a genome engineering company that enables access …
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine …See details»
ABOUT SYNTHEGO - Contentstack
ABOUT SYNTHEGO Synthego is a leading provider of genome engineering solutions. Our automated, full stack genome engineering platform enables broader access to CRISPR to …See details»
Company: Synthego - CRISPR Medicine
Synthego is a genome engineering company that enables life science research and the development of genomic medicines. With unparalleled CRISPR expertise, state-of-the-art …See details»
Synthego Company Profile - Office Locations, Competitors ... - Craft
Synthego has 5 employees at their 1 location, $259.54 m in total funding, and $20 m in annual revenue in Y 2018. See insights on Synthego including office locations, competitors, revenue, …See details»
Synthego - CRISPR Medicine
Synthego was founded to revolutionize genome engineering technology, helping translate genomics into the clinic and ultimately making engineered biological therapies accessible to all …See details»
Synthego Announces CEO Transition to Focus on Enabling CRISPR …
Mar 27, 2024 Synthego Corporation announces executive transition with Paul Dabrowski stepping down as CEO and Craig Christianson stepping in, alongside the spinout of EditCo …See details»
Synthego - Contacts, Employees, Board Members, Advisors
Organization. Synthego . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 4. Contacts 387. About. Synthego …See details»
Synthego Announces CEO Transition to Focus on Enabling CRISPR …
Mar 27, 2024 "Founding and growing Synthego the past 12 years has been the privilege of a lifetime," said Dabrowski. ... "I am honored to join this pioneering organization which plays an …See details»
Synthego: The One Stop Shop for Revolutionary Genetic Research
Nov 20, 2018 Synthego’s innovation has revolutionary potential across a very wide range of fields. Researchers working to understand impacts and applications of gene editing for …See details»
Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing …
Jun 28, 2023 Synthego's Gene Engineering Platform, powered by advanced CRISPR technology, enables precise and efficient gene editing, enabling scientists to unlock the full …See details»
Synthego, AstraZeneca Ink Agreement for CRISPR Gene Editing …
5 days ago Synthego, a supplier of CRISPR services, has entered a strategic licensing agreement with AstraZeneca granting Synthego a global license to manufacture and distribute …See details»
Synthego Signs Strategic Agreement with AstraZeneca to
4 days ago REDWOOD CITY, Calif., Jan. 13, 2025 /PRNewswire/ -- Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global …See details»